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Background:  The Women’s Angiographic Vitamin and Estrogen (WAVE) trial was a randomized study of hormone replacement therapy and 
antioxidant vitamins effect on progression of atherosclerosis. No effect was found. Using this data set we evaluated whether progression of 
atherosclerosis was predicted by hemoglobin A1C.
Methods:  Women were eligible for inclusion with at least one coronary narrowing of >=50% at the time of an indicated angiogram. No intervention 
was allowed. Quantitative coronary angiography (QCA) was used to measure minimum luminal diameter (MLD) and average luminal diameter (ALD) 
at baseline and follow up in the original trial (320 subjects, 1735 coronary segments, a mean of six segments per subject). The QCA data was 
grouped based on HbA1C at baseline irrespective of a history of diabetes: HbA1C<6.0, 6=<HbA1C<7, HbA1C>=7. Also, data was grouped based on 
hypoglycemic medication use.
Results:  Patients with higher HbA1C showed a larger reduction in MLD and ALD at follow up. Subjects placed on insulin at a follow up visit showed 
the largest reduction in MLD and ALD.
Conclusion: In postmenopausal women, a higher HbA1C was associated with accelerated atherosclerosis. Those with insulin added at a follow 
up visit showed more accelerated atherosclerosis even compared to those on insulin throughout the study. This could indicate that worsening 
of diabetic disease burden, triggering the addition of insulin at follow up, affected progression of atherosclerosis and not use of insulin itself. 
